Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer
Clinical trial NCT06697366 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06697366
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2026-05-20
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.